Australia's Bioxyne hits nearly 8-year high on cannabis firm deal
** Bioxyne BXN.AX rises as much as 9.5% to A$0.069, highest since June 5, 2018 ** Pharmaceutical firm says its unit entered into manufacturing deal with Canada-based Aurora Cannabis ACB.TO ** Adds deal covers supply of medicinal cannabis oils into Australian market ** YTD, BXN up more than 60% (Reporting by Rajasik Mukherjee in Bengaluru) ((Rajasik.Mukherjee@thomsonreuters.com))
Recent news on Aurora Cannabis
See all newsCanada Research Roundup: Allied Gold, I80 Gold, Polaris Renewable Energy
Canada's Aurora Cannabis Q2 revenue beats estimates on international demand
Canada Research Roundup: Aecon Group, Enerflex, Sun Life Financial
Canada Research Roundup: Aurora Cannabis, Fortis, Toromont Industries
Aurora Cannabis surges on Organigram's higher takeover offer